318 related articles for article (PubMed ID: 22609309)
1. Successful mutation-specific chaperone therapy with 4-phenylbutyrate in a child with progressive familial intrahepatic cholestasis type 2.
Gonzales E; Grosse B; Cassio D; Davit-Spraul A; Fabre M; Jacquemin E
J Hepatol; 2012 Sep; 57(3):695-8. PubMed ID: 22609309
[TBL] [Abstract][Full Text] [Related]
2. Targeted pharmacotherapy in progressive familial intrahepatic cholestasis type 2: Evidence for improvement of cholestasis with 4-phenylbutyrate.
Gonzales E; Grosse B; Schuller B; Davit-Spraul A; Conti F; Guettier C; Cassio D; Jacquemin E
Hepatology; 2015 Aug; 62(2):558-66. PubMed ID: 25716872
[TBL] [Abstract][Full Text] [Related]
3. 4-phenylbutyrate enhances the cell surface expression and the transport capacity of wild-type and mutated bile salt export pumps.
Hayashi H; Sugiyama Y
Hepatology; 2007 Jun; 45(6):1506-16. PubMed ID: 17538928
[TBL] [Abstract][Full Text] [Related]
4. Improved liver function and relieved pruritus after 4-phenylbutyrate therapy in a patient with progressive familial intrahepatic cholestasis type 2.
Naoi S; Hayashi H; Inoue T; Tanikawa K; Igarashi K; Nagasaka H; Kage M; Takikawa H; Sugiyama Y; Inui A; Nagai T; Kusuhara H
J Pediatr; 2014 May; 164(5):1219-1227.e3. PubMed ID: 24530123
[TBL] [Abstract][Full Text] [Related]
5. Short-chain ubiquitination is associated with the degradation rate of a cell-surface-resident bile salt export pump (BSEP/ABCB11).
Hayashi H; Sugiyama Y
Mol Pharmacol; 2009 Jan; 75(1):143-50. PubMed ID: 18829893
[TBL] [Abstract][Full Text] [Related]
6. A novel mutation within a transmembrane helix of the bile salt export pump (BSEP, ABCB11) with delayed development of cirrhosis.
Stindt J; Ellinger P; Weissenberger K; Dröge C; Herebian D; Mayatepek E; Homey B; Braun S; Schulte am Esch J; Horacek M; Canbay A; Schmitt L; Häussinger D; Kubitz R
Liver Int; 2013 Nov; 33(10):1527-35. PubMed ID: 23758865
[TBL] [Abstract][Full Text] [Related]
7. Partial external biliary diversion in bile salt export pump deficiency: Association between outcome and mutation.
Ellinger P; Stindt J; Dröge C; Sattler K; Stross C; Kluge S; Herebian D; Smits SHJ; Burdelski M; Schulz-Jürgensen S; Ballauff A; Schulte Am Esch J; Mayatepek E; Häussinger D; Kubitz R; Schmitt L
World J Gastroenterol; 2017 Aug; 23(29):5295-5303. PubMed ID: 28839429
[TBL] [Abstract][Full Text] [Related]
8. Levels of plasma membrane expression in progressive and benign mutations of the bile salt export pump (Bsep/Abcb11) correlate with severity of cholestatic diseases.
Lam P; Pearson CL; Soroka CJ; Xu S; Mennone A; Boyer JL
Am J Physiol Cell Physiol; 2007 Nov; 293(5):C1709-16. PubMed ID: 17855769
[TBL] [Abstract][Full Text] [Related]
9. Clinical phenotype and molecular analysis of a homozygous ABCB11 mutation responsible for progressive infantile cholestasis.
Imagawa K; Hayashi H; Sabu Y; Tanikawa K; Fujishiro J; Kajikawa D; Wada H; Kudo T; Kage M; Kusuhara H; Sumazaki R
J Hum Genet; 2018 May; 63(5):569-577. PubMed ID: 29507376
[TBL] [Abstract][Full Text] [Related]
10. Relapsing features of bile salt export pump deficiency after liver transplantation in two patients with progressive familial intrahepatic cholestasis type 2.
Maggiore G; Gonzales E; Sciveres M; Redon MJ; Grosse B; Stieger B; Davit-Spraul A; Fabre M; Jacquemin E
J Hepatol; 2010 Nov; 53(5):981-6. PubMed ID: 20800306
[TBL] [Abstract][Full Text] [Related]
11. Discovery and structural development of small molecules that enhance transport activity of bile salt export pump mutant associated with progressive familial intrahepatic cholestasis type 2.
Misawa T; Hayashi H; Sugiyama Y; Hashimoto Y
Bioorg Med Chem; 2012 May; 20(9):2940-9. PubMed ID: 22464344
[TBL] [Abstract][Full Text] [Related]
12. Progressive familial intrahepatic cholestasis.
Jacquemin E
Clin Res Hepatol Gastroenterol; 2012 Sep; 36 Suppl 1():S26-35. PubMed ID: 23141890
[TBL] [Abstract][Full Text] [Related]
13. The mechanism of increased biliary lipid secretion in mice with genetic inactivation of bile salt export pump.
Gooijert KE; Havinga R; Wolters H; Wang R; Ling V; Tazuma S; Verkade HJ
Am J Physiol Gastrointest Liver Physiol; 2015 Mar; 308(5):G450-7. PubMed ID: 25552583
[TBL] [Abstract][Full Text] [Related]
14. Functional rescue of an ABCB11 mutant by ivacaftor: A new targeted pharmacotherapy approach in bile salt export pump deficiency.
Mareux E; Lapalus M; Amzal R; Almes M; Aït-Slimane T; Delaunay JL; Adnot P; Collado-Hilly M; Davit-Spraul A; Falguières T; Callebaut I; Gonzales E; Jacquemin E
Liver Int; 2020 Aug; 40(8):1917-1925. PubMed ID: 32433800
[TBL] [Abstract][Full Text] [Related]
15. De novo bile salt transporter antibodies as a possible cause of recurrent graft failure after liver transplantation: a novel mechanism of cholestasis.
Keitel V; Burdelski M; Vojnisek Z; Schmitt L; Häussinger D; Kubitz R
Hepatology; 2009 Aug; 50(2):510-7. PubMed ID: 19642168
[TBL] [Abstract][Full Text] [Related]
16. ATP8B1 and ABCB11 analysis in 62 children with normal gamma-glutamyl transferase progressive familial intrahepatic cholestasis (PFIC): phenotypic differences between PFIC1 and PFIC2 and natural history.
Davit-Spraul A; Fabre M; Branchereau S; Baussan C; Gonzales E; Stieger B; Bernard O; Jacquemin E
Hepatology; 2010 May; 51(5):1645-55. PubMed ID: 20232290
[TBL] [Abstract][Full Text] [Related]
17. Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis.
Jansen PL; Strautnieks SS; Jacquemin E; Hadchouel M; Sokal EM; Hooiveld GJ; Koning JH; De Jager-Krikken A; Kuipers F; Stellaard F; Bijleveld CM; Gouw A; Van Goor H; Thompson RJ; Müller M
Gastroenterology; 1999 Dec; 117(6):1370-9. PubMed ID: 10579978
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic differences in PFIC2 and BRIC2 correlate with protein stability of mutant Bsep and impaired taurocholate secretion in MDCK II cells.
Kagawa T; Watanabe N; Mochizuki K; Numari A; Ikeno Y; Itoh J; Tanaka H; Arias IM; Mine T
Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G58-67. PubMed ID: 17947449
[TBL] [Abstract][Full Text] [Related]
19. Generation of a bile salt export pump deficiency model using patient-specific induced pluripotent stem cell-derived hepatocyte-like cells.
Imagawa K; Takayama K; Isoyama S; Tanikawa K; Shinkai M; Harada K; Tachibana M; Sakurai F; Noguchi E; Hirata K; Kage M; Kawabata K; Sumazaki R; Mizuguchi H
Sci Rep; 2017 Feb; 7():41806. PubMed ID: 28150711
[TBL] [Abstract][Full Text] [Related]
20. Impaired expression and function of the bile salt export pump due to three novel ABCB11 mutations in intrahepatic cholestasis.
Noe J; Kullak-Ublick GA; Jochum W; Stieger B; Kerb R; Haberl M; Müllhaupt B; Meier PJ; Pauli-Magnus C
J Hepatol; 2005 Sep; 43(3):536-43. PubMed ID: 16039748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
